Bekir Cinar

1.5k total citations
29 papers, 1.3k citations indexed

About

Bekir Cinar is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cell Biology. According to data from OpenAlex, Bekir Cinar has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Cell Biology. Recurrent topics in Bekir Cinar's work include Prostate Cancer Treatment and Research (14 papers), Hippo pathway signaling and YAP/TAZ (11 papers) and Estrogen and related hormone effects (8 papers). Bekir Cinar is often cited by papers focused on Prostate Cancer Treatment and Research (14 papers), Hippo pathway signaling and YAP/TAZ (11 papers) and Estrogen and related hormone effects (8 papers). Bekir Cinar collaborates with scholars based in United States, Türkiye and Netherlands. Bekir Cinar's co-authors include Michael R. Freeman, Nishit K. Mukhopadhyay, Rosalyn M. Adam, Dolores Di Vizio, Jayoung Kim, Ahmet Alptekin, Michael L. Lu, Arrigo De Benedetti, Serhan Alkan and Keith R. Solomon and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

In The Last Decade

Bekir Cinar

29 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bekir Cinar United States 22 686 424 367 255 223 29 1.3k
Xuesong Ouyang United States 18 1.3k 1.9× 508 1.2× 137 0.4× 333 1.3× 419 1.9× 28 1.8k
Luis J. Leandro‐García Spain 20 781 1.1× 322 0.8× 147 0.4× 476 1.9× 532 2.4× 31 1.5k
Hui-Kuan Lin United States 10 1.3k 1.9× 290 0.7× 192 0.5× 274 1.1× 456 2.0× 10 1.6k
Michal Grzmil Switzerland 20 834 1.2× 166 0.4× 159 0.4× 187 0.7× 144 0.6× 32 1.2k
Yasir H. Ibrahim United States 12 1.1k 1.6× 305 0.7× 99 0.3× 249 1.0× 828 3.7× 22 1.6k
Salahaldin A. Tahir United States 20 900 1.3× 375 0.9× 967 2.6× 533 2.1× 526 2.4× 26 1.9k
Cristina Montero‐Conde Spain 20 585 0.9× 191 0.5× 134 0.4× 321 1.3× 389 1.7× 31 1.3k
Katharine Ellwood‐Yen United States 8 787 1.1× 531 1.3× 69 0.2× 287 1.1× 336 1.5× 10 1.3k
Susanna Leskelä Spain 22 577 0.8× 143 0.3× 154 0.4× 415 1.6× 457 2.0× 27 1.4k
Randy S. Schrecengost United States 13 1.1k 1.6× 333 0.8× 331 0.9× 218 0.9× 410 1.8× 19 1.5k

Countries citing papers authored by Bekir Cinar

Since Specialization
Citations

This map shows the geographic impact of Bekir Cinar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bekir Cinar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bekir Cinar more than expected).

Fields of papers citing papers by Bekir Cinar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bekir Cinar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bekir Cinar. The network helps show where Bekir Cinar may publish in the future.

Co-authorship network of co-authors of Bekir Cinar

This figure shows the co-authorship network connecting the top 25 collaborators of Bekir Cinar. A scholar is included among the top collaborators of Bekir Cinar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bekir Cinar. Bekir Cinar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cinar, Bekir, et al.. (2022). The Hippo effector YAP1/TEAD1 regulates EPHA3 expression to control cell contact and motility. Scientific Reports. 12(1). 3840–3840. 1 indexed citations
2.
Cinar, Bekir, et al.. (2021). The Hippo pathway: an emerging role in urologic cancers.. PubMed. 9(4). 301–317. 8 indexed citations
3.
Cinar, Bekir, et al.. (2020). Androgen attenuates the inactivating phospho–Ser-127 modification of yes-associated protein 1 (YAP1) and promotes YAP1 nuclear abundance and activity. Journal of Biological Chemistry. 295(25). 8550–8559. 12 indexed citations
4.
George, Alex, Idris O. Raji, Bekir Cinar, Ömer Küçük, & Adegboyega K. Oyelere. (2018). Design, synthesis, and evaluation of the antiproliferative activity of hydantoin-derived antiandrogen-genistein conjugates. Bioorganic & Medicinal Chemistry. 26(8). 1481–1487. 9 indexed citations
5.
Ready, Damien B., et al.. (2017). Mapping the STK4/Hippo signaling network in prostate cancer cell. PLoS ONE. 12(9). e0184590–e0184590. 25 indexed citations
6.
Mohanty, Sambit K., Kader Yagiz, Dinesh Pradhan, et al.. (2017). STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer. Oncotarget. 8(49). 85997–86010. 34 indexed citations
7.
Alptekin, Ahmet, et al.. (2015). YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer. Nature Communications. 6(1). 8126–8126. 89 indexed citations
8.
Alptekin, Ahmet, et al.. (2014). Overexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression. Epigenetics. 9(4). 634–643. 34 indexed citations
9.
Mukhopadhyay, Nishit K., Sungyong You, Matteo Morello, et al.. (2013). Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2. Oncogene. 33(25). 3235–3245. 26 indexed citations
10.
Mo, Zhicheng, et al.. (2013). Bruton tyrosine kinase is commonly overexpressed in mantle cell lymphoma and its attenuation by Ibrutinib induces apoptosis. Leukemia Research. 37(10). 1271–1277. 101 indexed citations
12.
Cinar, Bekir, Seçkin Akgül, Nishit K. Mukhopadhyay, et al.. (2011). MST1 Is a Multifunctional Caspase-Independent Inhibitor of Androgenic Signaling. Cancer Research. 71(12). 4303–4313. 34 indexed citations
13.
Soifer, Harris S., et al.. (2011). Direct Regulation of Androgen Receptor Activity by Potent CYP17 Inhibitors in Prostate Cancer Cells. Journal of Biological Chemistry. 287(6). 3777–3787. 62 indexed citations
14.
Mukhopadhyay, Nishit K., Jayoung Kim, Bekir Cinar, et al.. (2009). Heterogeneous Nuclear Ribonucleoprotein K Is a Novel Regulator of Androgen Receptor Translation. Cancer Research. 69(6). 2210–2218. 56 indexed citations
15.
Adam, Rosalyn M., Nishit K. Mukhopadhyay, Jayoung Kim, et al.. (2007). Cholesterol Sensitivity of Endogenous and Myristoylated Akt. Cancer Research. 67(13). 6238–6246. 107 indexed citations
16.
Freeman, Michael R., Bekir Cinar, Jayoung Kim, et al.. (2006). Transit of hormonal and EGF receptor-dependent signals through cholesterol-rich membranes. Steroids. 72(2). 210–217. 49 indexed citations
17.
Mukhopadhyay, Nishit K., Angeline Ferdinand, Bekir Cinar, et al.. (2006). Unraveling androgen receptor interactomes by an array-based method: Discovery of proto-oncoprotein c-Rel as a negative regulator of androgen receptor. Experimental Cell Research. 312(19). 3782–3795. 28 indexed citations
18.
Cinar, Bekir, Arrigo De Benedetti, & Michael R. Freeman. (2005). Post-Transcriptional Regulation of the Androgen Receptor by Mammalian Target of Rapamycin. Cancer Research. 65(7). 2547–2553. 59 indexed citations
19.
Freeman, Michael R., Bekir Cinar, & Michael L. Lu. (2005). Membrane rafts as potential sites of nongenomic hormonal signaling in prostate cancer. Trends in Endocrinology and Metabolism. 16(6). 273–279. 82 indexed citations
20.
Ye, Qinong, Bekir Cinar, Magnus Edlund, Leland W.K. Chung, & Haiyen E. Zhau. (2001). Inhibition of growth and cell cycle arrest of ARCaP human prostate cancer cells by ectopic expression of ER-α. Molecular and Cellular Biochemistry. 228(1-2). 105–110. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026